Advisory Services Network, LLC Genprex, Inc. Transaction History

Advisory Services Network, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$0.74 - $1.1 $12,716 - $18,903	17,185 New	17,185 $16,000
Q3 2021 Nov 05, 2021	SELL	$2.59 - $3.36 $2,849 - $3,696	-1,100 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$3.11 - $4.87 $3,421 - $5,357	1,100 New	1,100 $4,000
Q1 2021 May 24, 2021	SELL	$3.66 - $7.67 $3,660 - $7,670	-1,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.9 - $4.29 $2,900 - $4,290	1,000 New	1,000 $3,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.